Catheter Precision, Inc.

VTAK

Catheter Precision, Inc.

VTAK

Insider Sentiment (TTM):

Last Purchase:2024-01-23Last Sale:2025-01-29Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:77,180Shares Outstanding:2,191,831Institutional Ownership Pct.:3.52%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	1	0	0	1	1	0	3	1	0	1	4	6
Trading Securities Debt	-	-	-	1	1	-	-	-	-	-	-	-
Assets Current
Assets Current	3	1	0	2	2	1	3	2	0	2	4	6
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Inventory Net	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	3	2	0	0	0	0	0	0	0	0	0	0
Deferred Tax Assets Goodwill And Intangible Assets	-	-	-	-	-	-	-	25	25	26	-	27
Deferred Finance Costs Gross	-	-	-	-	-	-	-	-	0	-	-	-
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	19	22	-	-	-	-	-	-	-	-	-	-
Finite Lived Intangible Assets Net	-	21	15	23	23	24	24	-	-	-	26	-
Goodwill	13	10	-	-	-	-	-	-	-	-	-	-
Assets	37	35	16	25	26	25	28	27	26	28	31	33
Liabilities And Stockhold…
Accounts Payable Current	1	1	1	1	1	1	0	1	1	1	0	0
Accrued Liabilities Current	2	2	2	2	2	2	2	1	2	2	2	2
Notes Payable	-	-	-	-	-	-	-	0	0	0	-	-
Notes Payable Current	-	-	-	-	-	-	0	-	-	-	0	-
Liabilities Current
Liabilities Current	13	20	4	5	5	4	2	3	3	2	2	2
Interest Payable Current	-	-	-	-	-	0	-	0	0	-	-	-
Accrued Royalties Current	-	-	-	-	-	0	0	-	-	-	0	-
Contract With Customer Liability Current	0	0	-	-	-	-	-	-	-	-	-	-
Short Term Borrowings	-	7	-	-	-	-	-	-	-	-	-	-
Convertible Debt Current	0	0	0	-	-	-	0	-	-	-	-	-
Operating Lease Liability Current	1	1	0	0	0	0	0	0	0	0	0	0
Accrued Royalties Current And Noncurrent	-	-	-	-	-	-	-	10	9	7	-	-
Operating Lease Liability Noncurrent	1	1	0	0	0	0	0	0	0	0	0	0
Deferred Income Tax Liabilities Net	1	1	1	2	1	2	3	-	-	-	0	-
Long Term Notes Payable	-	-	-	-	-	0	2	-	-	-	0	9
Liabilities	20	26	9	19	19	17	16	14	12	9	10	11
Commitments And Contingen…
Commitments And Contingen…
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Stockholders Equity	18	9	7	6	7	8	12	13	14	19	21	22
Additional Paid In Capital	332	321	317	311	308	304	304	300	297	297	297	297
Retained Earnings Accumulated Deficit	-315	-311	-310	-304	-302	-296	-292	-287	-283	-278	-276	-275
Minority Interest	-0	-0	-0	-0	-0	-	0	-	-	-	-	-
Liabilities And Stockholders Equity	37	35	16	25	26	25	28	27	26	28	31	33
Series X Convertible Preferred Stock	-	-	-	-	-	-	-	-	0	-	-	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	-	0	-
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	500	500	500	60	60	60	500	30	30	300	30	300
Common Stock Shares Issued	4	3	2	2	19	9	0	3	1	8	1	7
Shares Outstanding	4	3	2	2	19	9	0	3	1	8	1	7

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	26.51%	-4.82%	-66.27%	-	-	-	-	-	-	-	-	-
2025	-30.00%	-23.33%	-43.33%	-27.78%	-25.15%	-28.36%	16.10%	-1.95%	-5.37%	-7.92%	-15.84%	-16.83%
2024	-9.09%	7.27%	-68.36%	-74.84%	-77.36%	-67.92%	-30.00%	6.00%	-20.00%	-14.71%	-29.41%	-11.76%
2023	-	-	-	-16.67%	-4.17%	4.17%	-2.50%	2.50%	42.50%	10.00%	6.00%	20.00%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.19	0.06	0.10	0.46	0.44	0.21	1.48	0.66	0.12	0.83	1.68	2.84
Quick Ratio	0.15	0.04	0.06	0.41	0.39	0.13	1.32	0.53	0.04	0.67	1.50	2.76
Working Capital	-10.94M	-18.49M	-3.52M	-2.86M	-2.60M	-3.24M	1.06M	-872.00K	-2.93M	-396.00K	1.69M	3.74M
Leverage & Debt
Debt to Equity	1.15	2.83	1.31	2.95	2.90	2.13	1.36	1.09	0.83	0.51	0.45	0.50
Interest Coverage TTM	-157.01	-105.22	-180.71	-132.71	-134.96	-283.77	-267.69	-269.73	-1,332.50	-4,750.33	-	-
Debt Ratio	0.54	0.74	0.58	0.75	0.74	0.68	0.58	0.52	0.45	0.34	0.31	0.33
Efficiency & Turnover
Asset Turnover TTM	0.06	0.04	0.04	0.03	0.02	0.02	0.01	0.01	0.01	0.01	0.02	0.01
Days Sales Outstanding TTM	22.40	56.99	50.14	57.50	66.92	59.95	89.95	69.98	93.76	63.60	113.13	53.47
Receivables Turnover TTM	16.30	6.40	7.28	6.35	5.45	6.09	4.06	5.22	3.89	5.74	3.23	6.83
Per Share Metrics
Diluted EPS TTM	-	-	-	-	-	-	-	-6.09	-13.59	-1.03	-12.99	-114.70
Free Cash Flow Per Share TTM	-3.22	-4.00	-7.70	-5.55	-11.27	-16.37	-54.36	-77.64	-9.83	-14.23	-37.66	-3.12
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	47.73%	91.52%	92.31%	92.60%	92.33%	90.02%	90.00%	90.48%	92.20%	94.31%	93.21%	-
Operating Profit Margin TTM	-1,000.26%	-1,794.77%	-2,581.56%	-1,963.42%	-2,361.83%	-2,536.80%	-2,676.90%	-2,704.01%	-2,444.95%	-3,246.24%	-17,673.98%	-26,667.83%
Net Profit Margin TTM	-693.26%	-1,460.20%	-2,098.05%	-3,087.67%	-4,068.17%	-4,817.26%	-5,190.71%	-3,128.82%	-2,360.32%	-1,741.91%	-16,147.51%	-24,860.51%
Growth Metrics
Net Revenue Growth (1Y)	219.17%	130.35%	95.00%	82.96%	37.61%	9.57%	-4.98%	27.07%	123.59%	322.12%	1,478.57%	597.78%
Net Income Growth (1Y)	-45.61%	-30.18%	-21.18%	80.55%	137.19%	203.01%	-69.45%	-84.01%	-87.28%	-91.29%	165.67%	189.19%
EPS Growth (1Y)	-86.21%	-81.08%	-87.47%	-85.24%	155.92%	279.04%	-2.28%	938.19%	-9.84%	-38.23%	399.91%	-54.94%
Valuation Metrics
P/E TTM	-0.18	-0.14	-0.12	-0.15	-0.13	-0.17	-0.07	-0.07	-8.25	-9.04	-0.59	-7.51
P/B TTM	0.14	0.24	0.28	0.52	0.49	0.48	0.12	0.06	5.93	3.73	1.97	26.79
P/S TTM	1.23	2.00	2.41	4.56	5.33	7.98	3.50	2.06	194.72	157.55	94.49	1,865.82
Market Cap	2.35M	2.21M	1.98M	3.33M	3.20M	3.84M	1.47M	820.44K	84.90M	69.17M	41.76M	585.87M
Enterprise Value	1.71M	8.61M	2.19M	2.25M	2.36M	3.39M	272.67K	-198.56K	84.88M	67.75M	38.38M	589.14M
Calculated Values
Free Cash Flow TTM	-8.92M	-8.77M	-8.32M	-7.32M	-7.91M	-9.72M	-9.34M	-8.38M	-7.44M	-10.57M	-20.70M	-21.83M
Net Debt	-643.00K	6.40M	210.00K	-1.08M	-838.00K	-450.00K	-1.20M	-1.02M	-16.00K	-1.42M	-3.38M	3.27M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-01-29Sale

Owner: Colombatto, Martin J

Title: -

Shares: 3

Price/Share: $0.40

Value: $1.20

Shares Owned: -

Relationship: Director

Ownership: Indirect

2024-01-23Purchase

Owner: Jenkins, David A

Title: Executive Chairman and CEO

Shares: 9,528

Price/Share: $0.60

Value: $5,716.80

Shares Owned: 329,856

Relationship: Director,Officer

Ownership: Direct

2024-01-19Purchase

Owner: Jenkins, David A

Title: Executive Chairman and CEO

Shares: 8,470

Price/Share: $0.42

Value: $3,557.40

Shares Owned: 310,800

Relationship: Director,Officer

Ownership: Direct

2024-01-16Purchase

Owner: Jenkins, David A

Title: Executive Chairman and CEO

Shares: 16,263

Price/Share: $0.39

Value: $6,342.57

Shares Owned: 293,860

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-01-29	Colombatto, Martin J	Director	-	Indirect	Sale	3	0.40	$1.20	0	4
2024-01-23	Jenkins, David A	Director,Officer	Executive Chairman and CEO	Direct	Purchase	9,528	0.60	$5,716.80	329,856	4
2024-01-19	Jenkins, David A	Director,Officer	Executive Chairman and CEO	Direct	Purchase	8,470	0.42	$3,557.40	310,800	4
2024-01-16	Jenkins, David A	Director,Officer	Executive Chairman and CEO	Direct	Purchase	16,263	0.39	$6,342.57	293,860	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

3.52%

Inst. Shares: 77,180

Shares Outstanding: 2,191,831

2025-12-31

6.33%

Inst. Shares: 68,379

Shares Outstanding: 1,080,617

2025-09-30

0.00%

Inst. Shares: 23

Shares Outstanding: 1,320,554

2025-06-30

2.42%

Inst. Shares: 323,310

Shares Outstanding: 13,336,088

2025-03-31

99.02%

Inst. Shares: 588,048

Shares Outstanding: 593,890

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	77,180	2,191,831	3.52%
2025-12-31	68,379	1,080,617	6.33%
2025-09-30	23	1,320,554	0.00%
2025-06-30	323,310	13,336,088	2.42%
2025-03-31	588,048	593,890	99.02%
2024-12-31	480,473	171,774	279.71%
2024-09-30	110,921	107,952	102.75%
2024-06-30	708,598	757,340	93.56%
2024-03-31	799,662	742,920	107.64%
2023-12-31	411,759	549,507	74.93%
2023-09-30	481,038	549,507	87.54%
2023-06-30	366,972	5,367,674	6.84%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Catheter Precision, Inc. (VTAK) — SEC Financial Statements & Analysis

Catheter Precision, Inc. (VTAK) is a surgical & medical instruments & apparatus company, incorporated in DE. Catheter Precision, Inc. trades on NYSE as: VTAK. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Catheter Precision, Inc. reported a 219.17% year-over-year revenue growth, a Gross Profit Margin of 47.73% (TTM), a Debt-to-Equity ratio of 1.15x, a Price-to-Sales (P/S) ratio of 1.23x (TTM), a Price-to-Book (P/B) ratio of 0.14x (TTM), at a market cap of $2.35M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 219.17%
Gross Profit Margin TTM: 47.73%
Debt To Equity: 1.15x
P/S TTM: 1.23x
P/B TTM: 0.14x
Market Cap: $2.35M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Catheter Precision, Inc. in?

Catheter Precision, Inc. (VTAK) operates in the Surgical & Medical Instruments & Apparatus industry.

What is VTAK's market cap?

Catheter Precision, Inc. (VTAK) has a market capitalization of $2.35M as of 2026-06-30.

What exchange does VTAK trade on?

Catheter Precision, Inc. (VTAK) trades on the NYSE.

Where is Catheter Precision, Inc. incorporated?

Catheter Precision, Inc. is incorporated in DE.